31 – 40 of 152
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’ disease biomarkers
(
- Contribution to journal › Article
-
Mark
Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
The impact of tau-PET in a selected memory clinic cohort : rationale and design of the TAP-TAU study
(
- Contribution to journal › Article
-
Mark
A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer’s Disease
(
- Contribution to journal › Scientific review
-
Mark
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217
(
- Contribution to journal › Article
-
Mark
Impact of simulated reduced injected dose on the assessment of amyloid PET scans
(
- Contribution to journal › Article
-
Mark
Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns
(
- Contribution to journal › Article
-
Mark
Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression : observational analysis
(
- Contribution to journal › Article
- 2023
-
Mark
Recruitment of pre-dementia participants : main enrollment barriers in a longitudinal amyloid-PET study
(
- Contribution to journal › Article